ES2048137T3 - Metodo y compuesto para el tratamiento de una infeccion hiv en mamiferos. - Google Patents

Metodo y compuesto para el tratamiento de una infeccion hiv en mamiferos.

Info

Publication number
ES2048137T3
ES2048137T3 ES91900012T ES91900012T ES2048137T3 ES 2048137 T3 ES2048137 T3 ES 2048137T3 ES 91900012 T ES91900012 T ES 91900012T ES 91900012 T ES91900012 T ES 91900012T ES 2048137 T3 ES2048137 T3 ES 2048137T3
Authority
ES
Spain
Prior art keywords
treatment
mammals
compound
hiv infection
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91900012T
Other languages
English (en)
Other versions
ES2048137T1 (es
Inventor
Erfle Volker
Torben Saermark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Original Assignee
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH filed Critical Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Publication of ES2048137T1 publication Critical patent/ES2048137T1/es
Application granted granted Critical
Publication of ES2048137T3 publication Critical patent/ES2048137T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBEN UN METODO Y UNA COMPOSICION PARA EL TRATAMIENTO DE LAS INFECCIONES CAUSADAS POR EL VIH EN MAMIFEROS QUE CONSISTE EN LA ADMINISTRACION DE UNA DOSIS SUBTOXICA EFECTIVA DE MELITINA AL MAMIFERO CON LO QUE SE INHIBE EL CRECIMIENTO DE LAS CELULAS INFECTADAS POR EL VIH O LA REPRODUCCION DEL VIRUS EN LAS CELULAS INFECTADAS DEL MAMIFERO.
ES91900012T 1989-12-07 1990-12-07 Metodo y compuesto para el tratamiento de una infeccion hiv en mamiferos. Expired - Lifetime ES2048137T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3940526 1989-12-07

Publications (2)

Publication Number Publication Date
ES2048137T1 ES2048137T1 (es) 1994-03-16
ES2048137T3 true ES2048137T3 (es) 1994-10-16

Family

ID=6395034

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900012T Expired - Lifetime ES2048137T3 (es) 1989-12-07 1990-12-07 Metodo y compuesto para el tratamiento de una infeccion hiv en mamiferos.

Country Status (11)

Country Link
EP (1) EP0504191B1 (es)
JP (1) JPH075475B2 (es)
KR (1) KR970005329B1 (es)
AT (1) ATE110278T1 (es)
AU (1) AU646652B2 (es)
BR (1) BR9007904A (es)
DE (2) DE504191T1 (es)
DK (1) DK0504191T3 (es)
ES (1) ES2048137T3 (es)
GR (1) GR930300031T1 (es)
WO (1) WO1991008753A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770688A (en) * 1989-12-07 1998-06-23 Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Method and composition for the treatment of mammalian HIV infection
DK82892D0 (da) * 1992-06-24 1992-06-24 Michael Hansen Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner
KR100361933B1 (ko) 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
ATE238427T1 (de) * 1995-03-09 2003-05-15 Austrian Nordic Biotherapeutic Vektoren, die therapeutische gene fuer antimikrobielle peptide enthalten, zur verwendung in der gentherapie
WO1999018983A1 (en) * 1997-10-15 1999-04-22 Alk-Abelló A/S Composition and method for treating an encephalomyelopathic, demyelinating or autoimmune disease
CN1434726A (zh) 2000-06-08 2003-08-06 拉卓拉药物公司 包含高分子量聚环氧乙烷的多价平台分子
RU2013135175A (ru) * 2011-01-03 2015-02-10 Ф. Хоффманн-Ля Рош Аг Фармацевтическая композиция комплекса антитела против дигоксигенина и дигоксигенина, конъюгированного с пептидом

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856936A (en) * 1973-05-07 1974-12-24 Schuyler Dev Corp Composition and method for cortisol control

Also Published As

Publication number Publication date
GR930300031T1 (en) 1993-06-07
DK0504191T3 (da) 1995-03-27
ES2048137T1 (es) 1994-03-16
ATE110278T1 (de) 1994-09-15
DE504191T1 (de) 1993-04-08
DE69011870D1 (de) 1994-09-29
KR970005329B1 (ko) 1997-04-15
JPH05504761A (ja) 1993-07-22
WO1991008753A1 (en) 1991-06-27
JPH075475B2 (ja) 1995-01-25
BR9007904A (pt) 1992-09-29
EP0504191B1 (en) 1994-08-24
AU646652B2 (en) 1994-03-03
EP0504191A1 (en) 1992-09-23
DE69011870T2 (de) 1994-12-15
AU6880891A (en) 1991-07-18

Similar Documents

Publication Publication Date Title
ES2188656T3 (es) Composicion antiviral para la cicatrizacion de una herida que contiene un piruvato, un antioxidante, una mezcla de acidos grasos saturados y un compuesto antiviral.
ES541103A0 (es) Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales
FI931097A0 (fi) Laekemedel, deras framstaellning och anvaendning vid bekaempning av smaertor och/eller inflammationen hos maenniskor och djur
DK143088A (da) Praeparat til behandling eller forhindring af virale infektioner
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
DE3688841D1 (de) Schwache interferondosierung fuer die erhoehung der impfstoffwirksamkeit.
DK109487A (da) Fungicid paa basis af et cyanopyrrolderivat
SE8406538D0 (sv) Novel derivatives of purine
ES2048137T3 (es) Metodo y compuesto para el tratamiento de una infeccion hiv en mamiferos.
DK538888A (da) Anvendelse af castanosperminestere til fremstilling af et farmaceutisk praeparat
ES2097759T3 (es) Anticuerpos especificos para el dominio de fijacion de cd4 de hiv.
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
SE8605503D0 (sv) Novel medicinal use
DK0484112T3 (da) Anvendelse af lithium ved behandlingen eller profylakse af Molluscum contagiosum
MX9301922A (es) Composiciones para el tratamiento de infeccion y enfermedad ocasionadas por el virus de hepatitis b (hbv).
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
PT859613E (pt) Utilizacao de flupirtina para a profilaxia e o tratamento de doencas associadas a uma alteracao do sistema celular hematopoietico
ES2014042A6 (es) Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo.
MX9302985A (es) Composicion farmaceutica para el tratamiento y la profilaxis de la ansiedad.
AU4829190A (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
ATE92760T1 (de) Verwendung des thiazol-derivates tiprotimod zur herstellung eines mittels zur therapie von virusinfektionen.
RU94031622A (ru) Гидрофильный бальзам для лечения и профилактики чесотки
GR3024236T3 (en) Use of leukoregulin for the treatment of animals infected with an envelope-virus
ES2137544T3 (es) Procedimiento para la preparacion de un preparado biologico terapeutico sin riesgo de infeccion por virus.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 504191

Country of ref document: ES